Why Oppenheimer Global fund is focusing on biotech as rates rise
27 Feb Why Oppenheimer Global fund is focusing on biotech as rates rise
Posted at 04:00h
in
News
by KMFSLLP
NEW YORK, Feb 27 (Reuters) – The recent volatility in the
global stock market may make some investors feel queasy, but it
is providing a buying opportunity in biotechnology stocks.
Sorry, the comment form is closed at this time.